Drug Shortage Report for MINT-PRAVASTATIN
Report ID | 217381 |
Drug Identification Number | 02317486 |
Brand name | MINT-PRAVASTATIN |
Common or Proper name | Pravastatin |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | PRAVASTATIN SODIUM |
Strength(s) | 40MG |
Dosage form(s) | TABLET TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottle |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2024-01-18 |
Estimated end date | 2024-04-30 |
Actual end date | 2024-03-25 |
Shortage status | Resolved |
Updated date | 2024-03-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-03-26 | English | Compare |
v4 | 2024-03-25 | French | Compare |
v3 | 2024-03-25 | English | Compare |
v2 | 2024-01-26 | French | Compare |
v1 | 2024-01-26 | English | Compare |
Showing 1 to 5 of 5